|
J Biol Chem, Vol. 274, Issue 50, 35461-35468, December 10, 1999
Functional Characterization of the Intermediate Isoform of the
Human Prolactin Receptor*
J. Bradford
Kline,
Heather
Roehrs, and
Charles V.
Clevenger
From the Department of Pathology and Laboratory Medicine,
University of Pennsylvania School of Medicine,
Philadelphia, Pennsylvania 19104
Prolactin-dependent signaling occurs
as the result of ligand-induced dimerization of the prolactin receptor
(PRLr). While three PRLr isoforms have been characterized in the rat,
studies have suggested the existence of several human isoforms in
breast carcinoma species and normal tissues. Reverse transcription
polymerase chain reaction was performed on mRNA isolated from the
breast carcinoma cell line T47D, revealing two predominant receptor
isoforms: the previously described long PRLr and a novel human
intermediate PRLr. The nucleotide sequence of the intermediate isoform
was found to be identical to the long isoform except for a 573-base pair deletion occurring at a consensus splice site, resulting in a
frameshift and truncated intracytoplasmic domain. Scatchard analysis of
the intermediate PRLr revealed an affinity for PRL comparable with the
long PRLr. While Ba/F3 transfectants expressing the long PRLr
proliferated in response to PRL, intermediate PRLr transfectants
exhibited modest incorporation of [3H]thymidine.
Significantly, however, both the long and intermediate PRLr were
equivalent in their inhibition of apoptosis of the Ba/F3 transfectants
after PRL treatment. The activation of proximal signaling molecules
also differed between isoforms. Upon ligand binding, Jak2 and Fyn were
activated in CHO-K1 cells transiently transfected with the long PRLr.
In contrast, the intermediate PRLr transfectants showed equivalent
levels of Jak2 activation but only minimal activation of Fyn. Last,
Northern analysis revealed variable tissue expression of intermediate
PRLr transcript that differed from that of the long PRLr. Taken
together, differences in signaling and tissue expression suggest that
the human intermediate PRLr differs from the long PRLr in physiological function.
*
This study was supported in part by the National Institutes
of Health grants 2R01CA69294 (to C. V. C.) and 1F32DK09727 (to J. B. K.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF166329.
To whom correspondence should be addressed: Dept. of Pathology & Laboratory Medicine, University of Pennsylvania Medical Center, 509 Stellar-Chance Labs, 422 Curie Blvd., Philadelphia, PA 19104. E-mail:
clevengc@mail.med.upenn.edu.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y.-L. Xie, S. A. Hassan, A. M. Qazi, C. H. Tsai-Morris, and M. L. Dufau
Intramolecular Disulfide Bonds of the Prolactin Receptor Short Form Are Required for Its Inhibitory Action on the Function of the Long Form of the Receptor
Mol. Cell. Biol.,
May 15, 2009;
29(10):
2546 - 2555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Galsgaard, B. B. Rasmussen, C. G. Folkesson, L. M. Rasmussen, M. W. Berchtold, L. Christensen, and S. Panina
Re-evaluation of the prolactin receptor expression in human breast cancer
J. Endocrinol.,
April 1, 2009;
201(1):
115 - 128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Dail, L. A. Shack, J. E. Chambers, and S. C. Burgess
Global Liver Proteomics of Rats Exposed for 5 Days to Phenobarbital Identifies Changes Associated with Cancer and with CYP Metabolism
Toxicol. Sci.,
December 1, 2008;
106(2):
556 - 569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J Brennan, J. A Sharp, E. Khalil, M. R Digby, S. L Mailer, C. M Lefevre, and K. R Nicholas
A population of mammary epithelial cells do not require hormones or growth factors to survive
J. Endocrinol.,
March 1, 2008;
196(3):
483 - 496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ben-Jonathan, C. R. LaPensee, and E. W. LaPensee
What Can We Learn from Rodents about Prolactin in Humans?
Endocr. Rev.,
February 1, 2008;
29(1):
1 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M A Hyatt, G S Gopalakrishnan, J Bispham, S Gentili, I C McMillen, S M Rhind, M T Rae, C E Kyle, A N Brooks, C Jones, et al.
Maternal nutrient restriction in early pregnancy programs hepatic mRNA expression of growth-related genes and liver size in adult male sheep
J. Endocrinol.,
January 1, 2007;
192(1):
87 - 97.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Gadd and C. V. Clevenger
Ligand-Independent Dimerization of the Human Prolactin Receptor Isoforms: Functional Implications
Mol. Endocrinol.,
November 1, 2006;
20(11):
2734 - 2746.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Qazi, C.-H. Tsai-Morris, and M. L. Dufau
Ligand-Independent Homo- and Heterodimerization of Human Prolactin Receptor Variants: Inhibitory Action of the Short Forms by Heterodimerization
Mol. Endocrinol.,
August 1, 2006;
20(8):
1912 - 1923.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-C. Lu, T. M. Piazza, and L. A. Schuler
Proteasomes Mediate Prolactin-induced Receptor Down-regulation and Fragment Generation in Breast Cancer Cells
J. Biol. Chem.,
October 7, 2005;
280(40):
33909 - 33916.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Gutzman, S. E. Nikolai, D. E. Rugowski, J. J. Watters, and L. A. Schuler
Prolactin and Estrogen Enhance the Activity of Activating Protein 1 in Breast Cancer Cells: Role of Extracellularly Regulated Kinase 1/2-Mediated Signals to c-fos
Mol. Endocrinol.,
July 1, 2005;
19(7):
1765 - 1778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Tan, D. A. Johnson, W. Wu, L. Zeng, Y. H. Chen, W. Y. Chen, B. K. Vonderhaar, and A. M. Walker
Unmodified Prolactin (PRL) and S179D PRL-Initiated Bioluminescence Resonance Energy Transfer between Homo- and Hetero-Pairs of Long and Short Human PRL Receptors in Living Human Cells
Mol. Endocrinol.,
May 1, 2005;
19(5):
1291 - 1303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Gutzman, D. E. Rugowski, M. D. Schroeder, J. J. Watters, and L. A. Schuler
Multiple Kinase Cascades Mediate Prolactin Signals to Activating Protein-1 in Breast Cancer Cells
Mol. Endocrinol.,
December 1, 2004;
18(12):
3064 - 3075.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Meng, C.-H. Tsai-Morris, and M. L. Dufau
Human Prolactin Receptor Variants in Breast Cancer: Low Ratio of Short Forms to the Long-Form Human Prolactin Receptor Associated with Mammary Carcinoma
Cancer Res.,
August 15, 2004;
64(16):
5677 - 5682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, K. G. Suresh Kumar, W. Tang, V. S. Spiegelman, and S. Y. Fuchs
Negative Regulation of Prolactin Receptor Stability and Signaling Mediated by SCF{beta}-TrCP E3 Ubiquitin Ligase
Mol. Cell. Biol.,
May 1, 2004;
24(9):
4038 - 4048.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Schroeder, J. L. Brockman, A. M. Walker, and L. A. Schuler
Inhibition of Prolactin (PRL)-Induced Proliferative Signals in Breast Cancer Cells by a Molecular Mimic of Phosphorylated PRL, S179D-PRL
Endocrinology,
December 1, 2003;
144(12):
5300 - 5307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Olayioye, M. A. Guthridge, F. C. Stomski, A. F. Lopez, J. E. Visvader, and G. J. Lindeman
Threonine 391 Phosphorylation of the Human Prolactin Receptor Mediates a Novel Interaction with 14-3-3 Proteins
J. Biol. Chem.,
August 29, 2003;
278(35):
32929 - 32935.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. G. Sheffield and J. J. Gavinski
Proteomics Methods for Probing Molecular Mechanisms in Signal Transduction
J Dairy Sci,
July 1, 2003;
86(13_suppl):
E115 - 124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ling, L. Svensson, B. Oden, B. Weijdegard, B. Eden, S. Eden, and H. Billig
Identification of Functional Prolactin (PRL) Receptor Gene Expression: PRL Inhibits Lipoprotein Lipase Activity in Human White Adipose Tissue
J. Clin. Endocrinol. Metab.,
April 1, 2003;
88(4):
1804 - 1808.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.M. Hair, F. C.W. Wu, and G. A. Lincoln
An investigation of the effectiveness of testosterone implants in combination with the prolactin inhibitor quinagolide in the suppression of spermatogenesis in men
Hum. Reprod.,
April 1, 2003;
18(4):
749 - 755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. G. Sheffield and J. J. Gavinski
Proteomics methods for probing molecular mechanisms in signal transduction
J Anim Sci,
March 1, 2003;
81(suppl_3):
48 - 57.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. V. Clevenger, P. A. Furth, S. E. Hankinson, and L. A. Schuler
The Role of Prolactin in Mammary Carcinoma
Endocr. Rev.,
February 1, 2003;
24(1):
1 - 27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-C. Lu, P. Scott, G. J. Strous, and L. A. Schuler
Multiple Internalization Motifs Differentially Used by Prolactin Receptor Isoforms Mediate Similar Endocytic Pathways
Mol. Endocrinol.,
November 1, 2002;
16(11):
2515 - 2527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Kline, M. A. Rycyzyn, and C. V. Clevenger
Characterization of a Novel and Functional Human Prolactin Receptor Isoform ({Delta}S1PRLr) Containing Only One Extracellular Fibronectin-Like Domain
Mol. Endocrinol.,
October 1, 2002;
16(10):
2310 - 2322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.M. Hair, O. Gubbay, H.N. Jabbour, and G.A. Lincoln
Prolactin receptor expression in human testis and accessory tissues: localization and function
Mol. Hum. Reprod.,
July 1, 2002;
8(7):
606 - 611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Rycyzyn and C. V. Clevenger
The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer
PNAS,
May 1, 2002;
(2002)
92160699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Schroeder, J. Symowicz, and L. A. Schuler
PRL Modulates Cell Cycle Regulators in Mammary Tumor Epithelial Cells
Mol. Endocrinol.,
January 1, 2002;
16(1):
45 - 57.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ben-Jonathan and R. Hnasko
Dopamine as a Prolactin (PRL) Inhibitor
Endocr. Rev.,
December 1, 2001;
22(6):
724 - 763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Gill, D Peston, B K Vonderhaar, and S Shousha
Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study
J. Clin. Pathol.,
December 1, 2001;
54(12):
956 - 960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. P. Vlahos, E. M. Bugg, M. J. Shamblott, J. Y. Phelps, J. D. Gearhart, and H. A. Zacur
Prolactin receptor gene expression and immunolocalization of the prolactin receptor in human luteinized granulosa cells
Mol. Hum. Reprod.,
November 1, 2001;
7(11):
1033 - 1038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C V Clevenger and J B Kline
Prolactin receptor signal transduction
Lupus,
October 1, 2001;
10(10):
706 - 718.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R Hooghe, Z Dogusan, N Martens, B Velkeniers, and E L Hooghe-Peters
Effects of prolactin on signal transduction and gene expression: possible relevance for systemic lupus erythematosus
Lupus,
October 1, 2001;
10(10):
719 - 727.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H. Lee and A. M. Edwards
Stimulation of DNA synthesis and c-fos mRNA expression in primary rat hepatocytes by estrogens
Carcinogenesis,
September 1, 2001;
22(9):
1473 - 1481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Kline, D. J. Moore, and C. V. Clevenger
Activation and Association of the Tec Tyrosine Kinase with the Human Prolactin Receptor: Mapping of a Tec/Vav1-Receptor Binding Site
Mol. Endocrinol.,
May 1, 2001;
15(5):
832 - 841.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Z.-Z. Hu, J. Meng, and M. L. Dufau
Isolation and Characterization of Two Novel Forms of the Human Prolactin Receptor Generated by Alternative Splicing of a Newly Identified Exon 11
J. Biol. Chem.,
October 26, 2001;
276(44):
41086 - 41094.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|